Delivery Order SPE2DB22D3016-SPE2DB25FAYL1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 8, 2025, with the place of performance in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader contract vehicle with the Defense Logistics...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,664.58 firm fixed price delivery order for Zepbound 5 mg/0.5 ml pens on May 8, 2025, with completion scheduled for May 9, 2025. This competitively awarded, non-set-aside contract represents a single-line item pharmaceutical delivery to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $46,091.55 for Zepbound 5 mg/0.5 ml pens on June 30, 2025, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction executed through AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with a ceiling value of $2,890.34. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is non-competitive and represents a single delivery order under the company's larger indefinite delivery contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $15,401.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on June 3, 2025, with an ultimate completion date of June 4, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. The place of performance...
- The Defense Logistics Agency awarded a $17,573.28 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, issued under a firm fixed-price delivery order contract, represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a ceiling value of $13,460.35. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Zepbound 10 mg/0.5 mL pens valued at $7,637.15 with a completion date of June 18, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAYL1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens valued at $30,993.63, with a firm fixed price structure and no set-aside designation. The award was executed on June 5, 2025, with an ultimate completion date of June 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a continuation of the company's ongoing pharmaceutical supply relationship with DLA's Medical Supply Chain. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 2026. That comprehensive IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Zepbound delivery order reflects AmerisourceBergen's established capacity to meet federal medical procurement requirements through competitive procurement and its role as a critical pharmaceutical distributor supporting Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.0k | 6/5/25 |